STATIN UTILIZATION AMONG PATIENTS WITH DIABETES IN AN EMPLOYEE SPONSORED PHARMACIST PROGRAM

OBJECTIVES: Upon enrollment in the Patient Pharmacist Partnerships (P3) program, pharmacists conduct Comprehensive Medication Therapy Management (CMTM) monthly for the first three months, and then quarterly thereafter, with medications lists documented at each encounter. Statin use is recommended among patients with diabetes and utilization of this medication is indicative of good quality diabetes care. Quality metric NQF# 2712 assesses the proportion of people with diabetes aged 40-75 years on a statin. The objective of this study is to characterize changes in the use of statin therapy among P3 enrollees with diabetes. METHODS: The dataset used includes medication lists of P3 enrollees from each encounter in the mid-Atlantic region from two participating employers. Patients were included in the study if they were between 40-75 years old and had diabetes denned by the presence of anti-hyperglycemic medication and followed-up in at least one additional time point. NQF# 2712 is the proportion of statin utilized among diabetes patients. Therefore, we used chi-square tests to assess changes in this quality indicator at each time point (0.5, 1, 1.5, and 2 years) compared to program entry. RESULTS: There were 401 enrollees with at least 1 encounter with mean age of 56.4 years (SD: 7.7), 215 (53.6%) female, and 203 (50.6%) white. The proportion of statin utilization (range 27.5%-28.1%) (p>0.05) remained unchanged at 0.5 and 1 years. At 1.5 and 2 years, there were increases in statin utilization from 24.24% to 28.79% (p